MedTrace Logo

Clinical Study Of Migraine Evolution

NCT00460005 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2008-04-15

No results posted yet for this study

Summary

Understanding the speed at which migraine headaches develop is of importance to patients. Determining the proportions in which different headache pain build-up occurs, may provide health care practitioners with valuable information with which to prescribe the most appropriate treatment. Patients who experience a slow pain build-up may gain more benefit from medications which have a slow onset of effect, high tolerability and long action. Conversely, medications with a rapid onset of effect may be of greater benefit to patients who experience rapid onset of migraine pain.

Conditions

  • Migraine Headache

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials, M.D. · GlaxoSmithKline

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00460005 on ClinicalTrials.gov